Human thymus medullary epithelial cells promote regulatory T-cell generation by stimulating interleukin-2 production via ICOS ligand

Cell Death and Disease

Volumn 5, Issue 9, 2014, Pages

  Nazzal, D ^a,b,c,d   Gradolatto, A ^a,b,c,d   Truffault, F ^a,b,c,d   Bismuth, J ^a,b,c,d   Berrih Aknin, S ^a,b,c,d  

^a Sorbonne Université   (France)

^b CNRS   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d AIM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE T CELL COSTIMULATOR LIGAND; INTERLEUKIN 2; NEUTRALIZING ANTIBODY; CARRIER PROTEIN; ICOSLG PROTEIN, HUMAN; MNAT1 PROTEIN, HUMAN;

ADULT; ANIMAL TISSUE; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELLS BY BODY ANATOMY; CYTOKINE PRODUCTION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE CULTURE; LYMPHOCYTE FUNCTION; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PURIFICATION; REGULATORY T LYMPHOCYTE; THYMUS; ADOLESCENT; COCULTURE; CYTOLOGY; FEMALE; IMMUNOLOGY; INFANT; MALE; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; CARRIER PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHILD, PRESCHOOL; COCULTURE TECHNIQUES; EPITHELIAL CELLS; FEMALE; HUMANS; INDUCIBLE T-CELL CO-STIMULATOR LIGAND; INFANT; INFANT, NEWBORN; INTERLEUKIN-2; MALE; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; YOUNG ADULT;

EID: 84927737284     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.377     Document Type: Article

References (52)

1. Rucci F, Poliani PL, Caraffi S, Paganini T, Fontana E, Giliani S et al. Abnormalities of thymic stroma may contribute to immune dysregulation in murine models of leaky severe combined immunodeficiency. Front Immunol 2011; 2: 15.
2. Gascoigne NR, Palmer E. Signaling in thymic selection. Curr Opin Immunol 2011; 23: 207-212.
3. Anderson G, Takahama Y. Thymic epithelial cells: working class heroes for T cell development and repertoire selection. Trends Immunol 2012; 33: 256-263.
4. Naquet P, Naspetti M, Boyd R. Development, organization and function of the thymic medulla in normal, immunodeficient or autoimmune mice. Semin Immunol 1999; 11: 47-55.
5. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164.
6. Abbas AK, Benoist C, Bluestone JA, Campbell DJ, Ghosh S, Hori S et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol 2013; 14: 307-308.
7. Kretschmer K, Heng TS, von Boehmer H. De novo production of antigen-specific suppressor cells in vivo. Nat Protoc 2006; 1: 653-661.
8. Long SA, Buckner JH. CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game. J Immunol 2011; 187: 2061-2066.
9. Brusko TM, Putnam AL, Bluestone JA. Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol Rev 2008; 223: 371-390.
10. Fontenot JD, Dooley JL, Farr AG, Rudensky AY. Developmental regulation of Foxp3 expression during ontogeny. J Exp Med 2005; 202: 901-906.
11. Lee HM, Bautista JL, Hsieh CS. Thymic and peripheral differentiation of regulatory T cells. Adv Immunol 2011; 112: 25-71.
12. Liston A, Nutsch KM, Farr AG, Lund JM, Rasmussen JP, Koni PA et al. Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc Natl Acad Sci USA 2008; 105: 11903-11908.
13. Zou T, Caton AJ, Koretzky GA, Kambayashi T. Dendritic cells induce regulatory T cell proliferation through antigen-dependent and-independent interactions. J Immunol 2010; 185: 2790-2799.
14. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol 2006; 6: 127-135.
15. Lio C-WJ, Hsieh C-S. A two-step process for thymic regulatory T cell development. Immunity 2008; 28: 100-111.
16. Hanabuchi S, Ito T, Park WR, Watanabe N, Shaw JL, Roman E et al. Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus. J Immunol 2010; 184: 2999-3007.
17. Watanabe N, Wang YH, Lee HK, Ito T, Wang YH, CaoWet al. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005; 436: 1181-1185.
18. Martin-Gayo E, Sierra-Filardi E, Corbi AL, Toribio ML. Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood 2010; 115: 5366-5375.
19. Aschenbrenner K, D'Cruz LM, Vollmann EH, Hinterberger M, Emmerich J, Swee LK et al. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat Immunol 2007; 8: 351-358.
20. Bayer A, Yu A, Malek T. Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells. J Immunol 2007; 178: 4062-4133.
21. Vang KB, Yang J, Mahmud SA, Burchill MA, Vegoe AL, Farrar MA. IL-2,-7, and-15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development. J Immunol 2008; 181: 3285-3290.
22. Bayer AL, Lee JY, de la Barrera A, Surh CD, Malek TR. A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells. J Immunol 2008; 181: 225-234.
23. Ito T, Hanabuchi S, Wang Y-H, Park W, Arima K, Bover L et al. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 2008; 28: 870-950.
24. Tulic MK, Andrews D, Crook ML, Charles A, Tourigny MR, Moqbel R et al. Changes in thymic regulatory T-cell maturation from birth to puberty: differences in atopic children. J Allergy Clin Immunol 2012; 129: 199-206; e191-194.
25. Cufi P, Dragin N, Weiss JM, Martinez-Martinez P, De Baets MH, Roussin R et al. Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis. Ann Neurol 2013; 73: 281-293.
26. Le Panse R, Berrih-Aknin S. Thymic myoid cells protect thymocytes from apoptosis and modulate their differentiation: implication of the ERK and Akt signaling pathways. Cell Death Differ 2005; 12: 463-472.
27. Gyulkhandanyan AV, Mutlu A, Freedman J, Leytin V. Markers of platelet apoptosis: methodology and applications. J Thromb Thrombolysis 2012; 33: 397-411.
28. Wlodkowic D, Telford W, Skommer J, Darzynkiewicz Z. Apoptosis and beyond: cytometry in studies of programmed cell death. Methods Cell Biol 2011; 103: 55-98.
29. Sarosiek KA, Ni Chonghaile T, Letai A. Mitochondria: gatekeepers of response to chemotherapy. Trends Cell Biol 2013; 23: 612-619.
30. Spence PJ, Green EA. Foxp3+ regulatory T cells promiscuously accept thymic signals critical for their development. Proc Natl Acad Sci USA 2008; 105: 973-978.
31. Jiang Q, Su H, Knudsen G, Helms W, Su L. Delayed functional maturation of natural regulatory T cells in the medulla of postnatal thymus: role of TSLP. BMC Immunol 2006; 7: 6.
32. Cowan JE, Parnell SM, Nakamura K, Caamano JH, Lane PJ, Jenkinson EJ et al. The thymic medulla is required for Foxp3+ regulatory but not conventional CD4+ thymocyte development. J Exp Med 2013; 210: 675-681.
33. Wirnsberger G, Mair F, Klein L. Regulatory T cell differentiation of thymocytes does not require a dedicated antigen-presenting cell but is under T cell-intrinsic developmental control. Proc Natl Acad Sci USA 2009; 106: 10278-10283.
34. Coquet JM, Ribot JC, Babala N, Middendorp S, van der Horst G, Xiao Y et al. Epithelial and dendritic cells in the thymic medulla promote CD4+Foxp3+ regulatory T cell development via the CD27-CD70 pathway. J Exp Med 2013; 210: 715-728.
35. Di Ianni M, Del Papa B, De Ioanni M, Moretti L, Bonifacio E, Cecchini D et al. Mesenchymal cells recruit and regulate T regulatory cells. Exp Hematol 2008; 36: 309-318.
36. Pinchuk IV, Beswick EJ, Saada JI, Boya G, Schmitt D, Raju GS et al. Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells. Gastroenterology 2011; 140: 2019-2030.
37. Bonito AJ, Aloman C, Fiel MI, Danzl NM, Cha S, Weinstein EG et al. Medullary thymic epithelial cell depletion leads to autoimmune hepatitis. J Clin Invest 2013; 123: 3510-3524.
38. Grinberg-Bleyer Y, Saadoun D, Baeyens A, Billiard F, Goldstein J, Grégoire S et al. Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. J Clin Invest 2010; 120: 4558-4568.
39. Tischner D, Wiegers GJ, Fiegl H, Drach M, Villunger A. Mutual antagonism of TGF-beta and Interleukin-2 in cell survival and lineage commitment of induced regulatory T cells. Cell Death Differ 2012; 19: 1277-1287.
40. Fujimoto M, Nakano M, Terabe F, Kawahata H, Ohkawara T, Han Y et al. The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cells. J Immunol 2011; 186: 32-40.
41. Yuan X, Malek TR. Cellular and molecular determinants for the development of natural and induced regulatory T cells. Hum Immunol 2012; 73: 773-782.
42. Malek T, Yu A, Vincek V, Scibelli P, Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002; 17: 167-178.
43. Kibe R, Zhang S, Guo D, Marrero L, Tsien F, Rodriguez P et al. IL-7Ralpha deficiency in p53null mice exacerbates thymocyte telomere erosion and lymphomagenesis. Cell Death Differ 2012; 19: 1139-1151.
44. Lischke T, Hegemann A, Gurka S, Vu Van D, Burmeister Y, Lam KP et al. Comprehensive analysis of CD4+ T cells in the decision between tolerance and immunity in vivo reveals a pivotal role for ICOS. J Immunol 2012; 189: 234-244.
45. Moulian N, Renvoize C, Desodt C, Serraf A, Berrih-Aknin S. Functional Fas expression in human thymic epithelial cells. Blood 1999; 93: 2660-2670.
46. Wakkach A, Chastre E, Bruand C, Cohen-Kaminsky S, Emami S, Gespach C et al. Phenotypic and functional characterization of human thymic stromal cell lines. Cell Mol Biol 2001; 47: 167-178.
47. Gouadon E, Lecerf F, German-Fattal M. Differential effects of cyclosporin A and tacrolimus on magnesium influx in Caco2 cells. J Pharm Pharm Sci 2012; 15: 389-398.
48. Wakkach A, Poea S, Chastre E, Gespach C, Lecerf F, De La Porte S et al. Establishment of a human thymic myoid cell line. Phenotypic and functional characteristics. Ame J Pathol 1999; 155: 1229-1240.
49. Balandina A, Lecart S, Dartevelle P, Saoudi A, Berrih-Aknin S. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 2005; 105: 735-741.
50. Moulian N, Truffault F, Gaudry-Talarmain YM, Serraf A, Berrih-Aknin S. In vivo and in vitro apoptosis of human thymocytes are associated with nitrotyrosine formation. Blood 2001; 97: 3521-3530.
51. Weiss JM, Cufi P, Bismuth J, Eymard B, Fadel E, Berrih-Aknin S et al. SDF-1/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients. Immunobiology 2013; 218: 373-381.
52. Gradolatto A, Nazzal D, Truffault F, Bismuth J, Fadel E, Foti M et al. Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-alpha. J Autoimmun 2014; 52: 53-63.